GeneDx Holdings Corp. (WGS) Deep Dive Video
Summary
GeneDx offers compelling long-term rare-disease genomics upside, but its valuation reset reflects a difficult transition marked by reimbursement pressure, rising competition, cash burn, and shaken investor confidence.
View WGS stock page · Read the WGS research report
Loading the video player…